In this study, we demonstrate that a novel combination of RAPA + Honokiol can effectively down-regulate the Ras-mTOR pathway to inhibit renal cancer cell growth; and it also inhibits PD-L1 expression to promote immune-mediated killing of renal cancer cells. Here, MTOR is linked to renal carcinoma.